All of the injured rats that received BPC 157 exhibited consistent clinical improvement, increasingly better motor function of the tail, no autotomy, and resolved spasticity by day 15
In our experience, patients with a subacute tendinopathy that has stalled at 6 to 12 weeks of physical therapy tend to notice a meaningful change in pain and range of motion within 3 to 4 weeks of starting a BPC-157 protocol
Research organizations value suppliers that provide transparent manufacturing processes and reliable batch-to-batch uniformity
For musculoskeletal indications, the guideline is progressive load reintroduction starting no earlier than 6 to 8 weeks, with full training not before 3 months for significant tendon injuries regardless of how good the patient feels
Available as an oral capsule, injectable, or nasal spray, BPC-157 is highly versatile and often used alongside other therapies for enhanced effect
Phetsouphanh, C